FDA Approval Summary: Enfortumab Vedotin plus Pembrolizumab for Cisplatin-Ineligible Locally Advanced or Metastatic Urothelial Carcinoma.
Maguire WF, Lee D, Weinstock C, Gao X, Bulik CC, Agrawal S, Chang E, Hamed SS, Bloomquist EW, Tang S, Pazdur R, Kluetz PG, Amiri-Kordestani L, Suzman DL.
Clin Cancer Res. 2024 May 15;30(10):2011-2016. doi: 10.1158/1078-0432.CCR-23-3738.
Impact of uptake time on image quality of [68 Ga]Ga-PSMA-11 PET/CT.
van der Sar ECA, Viol SLM, Braat AJAT, van Rooij R, Lam MGEH, de Jong HWAM, de Keizer B.
Med Phys. 2023 Dec;50(12):7619-7628. doi: 10.1002/mp.16429. Epub 2023 Apr 24.
Characterizing genetic interactions in human disease association studies using statistical epistasis networks.
Hu T, Sinnott-Armstrong NA, Kiralis JW, Andrew AS, Karagas MR, Moore JH.
BMC Bioinformatics. 2011 Sep 12;12:364. doi: 10.1186/1471-2105-12-364.
A Prognostic Gene Expression Signature in the Molecular Classification of Chemotherapy-naïve Urothelial Cancer is Predictive of Clinical Outcomes from Neoadjuvant Chemotherapy: A Phase 2 Trial of Dose-dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin with Bevacizumab in Urothelial Cancer.
McConkey DJ, Choi W, Shen Y, Lee IL, Porten S, Matin SF, Kamat AM, Corn P, Millikan RE, Dinney C, Czerniak B, Siefker-Radtke AO.
Eur Urol. 2016 May;69(5):855-62. doi: 10.1016/j.eururo.2015.08.034. Epub 2015 Sep 3.
Proteomic and bioinformatic profiling of neutrophils in CLL reveals functional defects that predispose to bacterial infections.
Subramaniam N, Bottek J, Thiebes S, Zec K, Kudla M, Soun C, de Dios Panal E, Lill JK, Pfennig A, Herrmann R, Bruderek K, Rahmann S, Brandau S, Johansson P, Reinhardt HC, Dürig J, Seiffert M, Bracht T, Sitek B, Engel DR.
Blood Adv. 2021 Mar 9;5(5):1259-1272. doi: 10.1182/bloodadvances.2020002949.
Accurate Segmentation of CT Male Pelvic Organs via Regression-Based Deformable Models and Multi-Task Random Forests.
Gao Y, Shao Y, Lian J, Wang AZ, Chen RC, Shen D.
IEEE Trans Med Imaging. 2016 Jun;35(6):1532-43. doi: 10.1109/TMI.2016.2519264. Epub 2016 Jan 18.
First Evaluation of PET-Based Human Biodistribution and Dosimetry of 18F-FAZA, a Tracer for Imaging Tumor Hypoxia.
Savi A, Incerti E, Fallanca F, Bettinardi V, Rossetti F, Monterisi C, Compierchio A, Negri G, Zannini P, Gianolli L, Picchio M.
J Nucl Med. 2017 Aug;58(8):1224-1229. doi: 10.2967/jnumed.113.122671. Epub 2017 Feb 16.
Recurring multifocal leiomyosarcoma of the urinary bladder 22 years after therapy for bilateral (hereditary) retinoblastoma: a case report and review of the literature.
Svajdler M Jr, Andrašina I, Ilenčíková D, Rychlý B, Piačková B.
Cesk Patol. 2012 Jan;48(1):44-8.
Chronic hepatitis C virus infection and genitourinary cancers: A case-control study.
Angelidakis G, Mahale P, Jonasch E, Jiang Y, Torres HA.
Semin Oncol. 2020 Apr-Jun;47(2-3):165-167. doi: 10.1053/j.seminoncol.2020.04.005. Epub 2020 May 21.
A multifactorial model of T cell expansion and durable clinical benefit in response to a PD-L1 inhibitor.
Leiserson MDM, Syrgkanis V, Gilson A, Dudik M, Gillett S, Chayes J, Borgs C, Bajorin DF, Rosenberg JE, Funt S, Snyder A, Mackey L.
PLoS One. 2018 Dec 31;13(12):e0208422. doi: 10.1371/journal.pone.0208422. eCollection 2018.
